Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
- Autores
- Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; Higuera de la Tijera, Fatima; Calışkan, Ali R.; Peralta, Mirta; Gerussi, Alessio; Massoumi, Hatef; Catana, Andreea M.; Purnak, Tugrul; Rigamonti, Cristina; Aldana, Andres J. G.; Khakoo, Nidah; Nazal, Leyla; Frager, Shalom; Demir, Nurhan; Irak, Kader; Melekoğlu Ellik, Zeynep; Kacmaz, Hüseyin; Balaban, Yasemin; Atay, Kadri; Eren, Fatih; Alvares da-Silva, Mario R.; Cristoferi, Laura; Urzua, Álvaro; Eşkazan, Tuğçe; Magro, Bianca; Snijders, Romee; Barutçu, Sezgin; Lytvyak, Ellina; Zazueta, Godolfino M.; Demirezer Bolat, Aylin; Aydın, Mesut; Amorós Martín, Alexandra Noemí; De Martin, Eleonora; Ekin, Nazım; Yıldırım, Sümeyra; Yavuz, Ahmet; Bıyık, Murat; Narro, Graciela C.; Bıyık, Murat; Kıyıcı, Murat; Kahramanoğlu Aksoy, Evrim; Vincent, Maria; Carr, Rotonya M.; Günşar, Fulya; Reyes, Eira C.; Harputluoğlu, Murat; Aloman, Costica; Gatselis, Nikolaos K.; Üstündağ, Yücel; Brahm, Javier; Vargas, Nataly C. E.; Güzelbulut, Fatih; Garcia, Sandro R.; Aguirre, Jonathan; Anders, Margarita; Ratusnu, Natalia; Hatemi, Ibrahim; Mendizabal, Manuel; Floreani, Annarosa; Fagiuoli, Stefano; Silva, Marcelo; Idilman, Ramazan; Satapathy, Sanjaya K.; Silveira, Marina; Drenth, Joost P. H.; Dalekos, George N.; N.Assis, David; Björnsson, Einar; Boyer, James L.; Yoshida, Eric M.; Invernizzi, Pietro; Levy, Cynthia; Montano Loza, Aldo J.; Schiano, Thomas D.; Ridruejo, Ezequiel; Wahlin, Staffan
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH.
Fil: Efe, Cumali. Harran University Hospita; Turquía
Fil: Lammert, Craig. University School of Medicine Indianapolis; Estados Unidos
Fil: Taşçılar, Koray. Universitat Erlangen-Nuremberg; Alemania
Fil: Dhanasekaran, Renumathy. University of Stanford; Estados Unidos
Fil: Ebik, Berat. Gazi Yasargil Education And Research Hospital; Turquía
Fil: Higuera de la Tijera, Fatima. Hospital General de México; México
Fil: Calışkan, Ali R.. No especifíca;
Fil: Peralta, Mirta. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; Argentina
Fil: Gerussi, Alessio. Università degli Studi di Milano; Italia
Fil: Massoumi, Hatef. No especifíca;
Fil: Catana, Andreea M.. Harvard Medical School; Estados Unidos
Fil: Purnak, Tugrul. University of Texas; Estados Unidos
Fil: Rigamonti, Cristina. Università del Piemonte Orientale ; Italia
Fil: Aldana, Andres J. G.. Fundacion Santa Fe de Bogota; Colombia
Fil: Khakoo, Nidah. Miami University; Estados Unidos
Fil: Nazal, Leyla. Clinica Las Condes; Chile
Fil: Frager, Shalom. Montefiore Medical Center; Estados Unidos
Fil: Demir, Nurhan. Haseki Training And Research Hospital; Turquía
Fil: Irak, Kader. Kanuni Sultan Suleyman Training And Research Hospital; Turquía
Fil: Melekoğlu Ellik, Zeynep. Ankara University Medical Faculty; Turquía
Fil: Kacmaz, Hüseyin. Adıyaman University; Turquía
Fil: Balaban, Yasemin. Hacettepe University; Turquía
Fil: Atay, Kadri. No especifíca;
Fil: Eren, Fatih. No especifíca;
Fil: Alvares da-Silva, Mario R.. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Cristoferi, Laura. Università degli Studi di Milano; Italia
Fil: Urzua, Álvaro. Universidad de Chile; Chile
Fil: Eşkazan, Tuğçe. Cerrahpaşa School of Medicine; Turquía
Fil: Magro, Bianca. No especifíca;
Fil: Snijders, Romee. No especifíca;
Fil: Barutçu, Sezgin. No especifíca;
Fil: Lytvyak, Ellina. University of Alberta; Canadá
Fil: Zazueta, Godolfino M.. Instituto Nacional de la Nutrición Salvador Zubiran; México
Fil: Demirezer Bolat, Aylin. Ankara City Hospital; Turquía
Fil: Aydın, Mesut. Van Yuzuncu Yil University; Turquía
Fil: Amorós Martín, Alexandra Noemí. No especifíca;
Fil: De Martin, Eleonora. No especifíca;
Fil: Ekin, Nazım. No especifíca;
Fil: Yıldırım, Sümeyra. No especifíca;
Fil: Yavuz, Ahmet. No especifíca;
Fil: Bıyık, Murat. Necmettin Erbakan University; Turquía
Fil: Narro, Graciela C.. Instituto Nacional de la Nutrición Salvador Zubiran; México
Fil: Bıyık, Murat. Uludag University; Turquía
Fil: Kıyıcı, Murat. No especifíca;
Fil: Kahramanoğlu Aksoy, Evrim. No especifíca;
Fil: Vincent, Maria. No especifíca;
Fil: Carr, Rotonya M.. University of Pennsylvania; Estados Unidos
Fil: Günşar, Fulya. No especifíca;
Fil: Reyes, Eira C.. Hepatology Unit. Hospital Militar Central de México; México
Fil: Harputluoğlu, Murat. Inönü University School of Medicine; Turquía
Fil: Aloman, Costica. Rush University Medical Center; Estados Unidos
Fil: Gatselis, Nikolaos K.. University Hospital Of Larissa; Grecia
Fil: Üstündağ, Yücel. No especifíca;
Fil: Brahm, Javier. Clinica Las Condes; Chile
Fil: Vargas, Nataly C. E.. Hospital Nacional Almanzor Aguinaga Asenjo; Perú
Fil: Güzelbulut, Fatih. No especifíca;
Fil: Garcia, Sandro R.. Hospital Iv Víctor Lazarte Echegaray; Perú
Fil: Aguirre, Jonathan. Hospital Angeles del Pedregal; México
Fil: Anders, Margarita. Hospital Alemán; Argentina
Fil: Ratusnu, Natalia. Hospital Regional de Ushuaia; Argentina
Fil: Hatemi, Ibrahim. No especifíca;
Fil: Mendizabal, Manuel. Universidad Austral; Argentina
Fil: Floreani, Annarosa. Università di Padova; Italia
Fil: Fagiuoli, Stefano. No especifíca;
Fil: Silva, Marcelo. Universidad Austral; Argentina
Fil: Idilman, Ramazan. No especifíca;
Fil: Satapathy, Sanjaya K.. No especifíca;
Fil: Silveira, Marina. University of Yale. School of Medicine; Estados Unidos
Fil: Drenth, Joost P. H.. No especifíca;
Fil: Dalekos, George N.. No especifíca;
Fil: N.Assis, David. University of Yale. School of Medicine; Estados Unidos
Fil: Björnsson, Einar. No especifíca;
Fil: Boyer, James L.. University of Yale. School of Medicine; Estados Unidos
Fil: Yoshida, Eric M.. University of British Columbia; Canadá
Fil: Invernizzi, Pietro. Università degli Studi di Milano; Italia
Fil: Levy, Cynthia. University of Miami; Estados Unidos
Fil: Montano Loza, Aldo J.. University of Alberta; Canadá
Fil: Schiano, Thomas D.. No especifíca;
Fil: Ridruejo, Ezequiel. Universidad Austral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina
Fil: Wahlin, Staffan. No especifíca; - Materia
-
AUTOIMMUNITY
AZATHIOPRINE
BUDESONIDE
LIVER TRANSPLANTATION
MERCAPTOPURINE
SARS-COV-2
COVID-19 - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/172868
Ver los metadatos del registro completo
id |
CONICETDig_47b0889836de89c6b677de77a529f218 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/172868 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitisEfe, CumaliLammert, CraigTaşçılar, KorayDhanasekaran, RenumathyEbik, BeratHiguera de la Tijera, FatimaCalışkan, Ali R.Peralta, MirtaGerussi, AlessioMassoumi, HatefCatana, Andreea M.Purnak, TugrulRigamonti, CristinaAldana, Andres J. G.Khakoo, NidahNazal, LeylaFrager, ShalomDemir, NurhanIrak, KaderMelekoğlu Ellik, ZeynepKacmaz, HüseyinBalaban, YaseminAtay, KadriEren, FatihAlvares da-Silva, Mario R.Cristoferi, LauraUrzua, ÁlvaroEşkazan, TuğçeMagro, BiancaSnijders, RomeeBarutçu, SezginLytvyak, EllinaZazueta, Godolfino M.Demirezer Bolat, AylinAydın, MesutAmorós Martín, Alexandra NoemíDe Martin, EleonoraEkin, NazımYıldırım, SümeyraYavuz, AhmetBıyık, MuratNarro, Graciela C.Bıyık, MuratKıyıcı, MuratKahramanoğlu Aksoy, EvrimVincent, MariaCarr, Rotonya M.Günşar, FulyaReyes, Eira C.Harputluoğlu, MuratAloman, CosticaGatselis, Nikolaos K.Üstündağ, YücelBrahm, JavierVargas, Nataly C. E.Güzelbulut, FatihGarcia, Sandro R.Aguirre, JonathanAnders, MargaritaRatusnu, NataliaHatemi, IbrahimMendizabal, ManuelFloreani, AnnarosaFagiuoli, StefanoSilva, MarceloIdilman, RamazanSatapathy, Sanjaya K.Silveira, MarinaDrenth, Joost P. H.Dalekos, George N.N.Assis, DavidBjörnsson, EinarBoyer, James L.Yoshida, Eric M.Invernizzi, PietroLevy, CynthiaMontano Loza, Aldo J.Schiano, Thomas D.Ridruejo, EzequielWahlin, StaffanAUTOIMMUNITYAZATHIOPRINEBUDESONIDELIVER TRANSPLANTATIONMERCAPTOPURINESARS-COV-2COVID-19https://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH.Fil: Efe, Cumali. Harran University Hospita; TurquíaFil: Lammert, Craig. University School of Medicine Indianapolis; Estados UnidosFil: Taşçılar, Koray. Universitat Erlangen-Nuremberg; AlemaniaFil: Dhanasekaran, Renumathy. University of Stanford; Estados UnidosFil: Ebik, Berat. Gazi Yasargil Education And Research Hospital; TurquíaFil: Higuera de la Tijera, Fatima. Hospital General de México; MéxicoFil: Calışkan, Ali R.. No especifíca;Fil: Peralta, Mirta. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; ArgentinaFil: Gerussi, Alessio. Università degli Studi di Milano; ItaliaFil: Massoumi, Hatef. No especifíca;Fil: Catana, Andreea M.. Harvard Medical School; Estados UnidosFil: Purnak, Tugrul. University of Texas; Estados UnidosFil: Rigamonti, Cristina. Università del Piemonte Orientale ; ItaliaFil: Aldana, Andres J. G.. Fundacion Santa Fe de Bogota; ColombiaFil: Khakoo, Nidah. Miami University; Estados UnidosFil: Nazal, Leyla. Clinica Las Condes; ChileFil: Frager, Shalom. Montefiore Medical Center; Estados UnidosFil: Demir, Nurhan. Haseki Training And Research Hospital; TurquíaFil: Irak, Kader. Kanuni Sultan Suleyman Training And Research Hospital; TurquíaFil: Melekoğlu Ellik, Zeynep. Ankara University Medical Faculty; TurquíaFil: Kacmaz, Hüseyin. Adıyaman University; TurquíaFil: Balaban, Yasemin. Hacettepe University; TurquíaFil: Atay, Kadri. No especifíca;Fil: Eren, Fatih. No especifíca;Fil: Alvares da-Silva, Mario R.. Universidade Federal do Rio Grande do Sul; BrasilFil: Cristoferi, Laura. Università degli Studi di Milano; ItaliaFil: Urzua, Álvaro. Universidad de Chile; ChileFil: Eşkazan, Tuğçe. Cerrahpaşa School of Medicine; TurquíaFil: Magro, Bianca. No especifíca;Fil: Snijders, Romee. No especifíca;Fil: Barutçu, Sezgin. No especifíca;Fil: Lytvyak, Ellina. University of Alberta; CanadáFil: Zazueta, Godolfino M.. Instituto Nacional de la Nutrición Salvador Zubiran; MéxicoFil: Demirezer Bolat, Aylin. Ankara City Hospital; TurquíaFil: Aydın, Mesut. Van Yuzuncu Yil University; TurquíaFil: Amorós Martín, Alexandra Noemí. No especifíca;Fil: De Martin, Eleonora. No especifíca;Fil: Ekin, Nazım. No especifíca;Fil: Yıldırım, Sümeyra. No especifíca;Fil: Yavuz, Ahmet. No especifíca;Fil: Bıyık, Murat. Necmettin Erbakan University; TurquíaFil: Narro, Graciela C.. Instituto Nacional de la Nutrición Salvador Zubiran; MéxicoFil: Bıyık, Murat. Uludag University; TurquíaFil: Kıyıcı, Murat. No especifíca;Fil: Kahramanoğlu Aksoy, Evrim. No especifíca;Fil: Vincent, Maria. No especifíca;Fil: Carr, Rotonya M.. University of Pennsylvania; Estados UnidosFil: Günşar, Fulya. No especifíca;Fil: Reyes, Eira C.. Hepatology Unit. Hospital Militar Central de México; MéxicoFil: Harputluoğlu, Murat. Inönü University School of Medicine; TurquíaFil: Aloman, Costica. Rush University Medical Center; Estados UnidosFil: Gatselis, Nikolaos K.. University Hospital Of Larissa; GreciaFil: Üstündağ, Yücel. No especifíca;Fil: Brahm, Javier. Clinica Las Condes; ChileFil: Vargas, Nataly C. E.. Hospital Nacional Almanzor Aguinaga Asenjo; PerúFil: Güzelbulut, Fatih. No especifíca;Fil: Garcia, Sandro R.. Hospital Iv Víctor Lazarte Echegaray; PerúFil: Aguirre, Jonathan. Hospital Angeles del Pedregal; MéxicoFil: Anders, Margarita. Hospital Alemán; ArgentinaFil: Ratusnu, Natalia. Hospital Regional de Ushuaia; ArgentinaFil: Hatemi, Ibrahim. No especifíca;Fil: Mendizabal, Manuel. Universidad Austral; ArgentinaFil: Floreani, Annarosa. Università di Padova; ItaliaFil: Fagiuoli, Stefano. No especifíca;Fil: Silva, Marcelo. Universidad Austral; ArgentinaFil: Idilman, Ramazan. No especifíca;Fil: Satapathy, Sanjaya K.. No especifíca;Fil: Silveira, Marina. University of Yale. School of Medicine; Estados UnidosFil: Drenth, Joost P. H.. No especifíca;Fil: Dalekos, George N.. No especifíca;Fil: N.Assis, David. University of Yale. School of Medicine; Estados UnidosFil: Björnsson, Einar. No especifíca;Fil: Boyer, James L.. University of Yale. School of Medicine; Estados UnidosFil: Yoshida, Eric M.. University of British Columbia; CanadáFil: Invernizzi, Pietro. Università degli Studi di Milano; ItaliaFil: Levy, Cynthia. University of Miami; Estados UnidosFil: Montano Loza, Aldo J.. University of Alberta; CanadáFil: Schiano, Thomas D.. No especifíca;Fil: Ridruejo, Ezequiel. Universidad Austral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; ArgentinaFil: Wahlin, Staffan. No especifíca;Wiley Blackwell Publishing, Inc2021-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/172868Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; et al.; Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis; Wiley Blackwell Publishing, Inc; Liver International; 42; 3; 11-2021; 607-6141478-3223CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1111/liv.15121info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:36:05Zoai:ri.conicet.gov.ar:11336/172868instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:36:05.269CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis |
title |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis |
spellingShingle |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis Efe, Cumali AUTOIMMUNITY AZATHIOPRINE BUDESONIDE LIVER TRANSPLANTATION MERCAPTOPURINE SARS-COV-2 COVID-19 |
title_short |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis |
title_full |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis |
title_fullStr |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis |
title_full_unstemmed |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis |
title_sort |
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis |
dc.creator.none.fl_str_mv |
Efe, Cumali Lammert, Craig Taşçılar, Koray Dhanasekaran, Renumathy Ebik, Berat Higuera de la Tijera, Fatima Calışkan, Ali R. Peralta, Mirta Gerussi, Alessio Massoumi, Hatef Catana, Andreea M. Purnak, Tugrul Rigamonti, Cristina Aldana, Andres J. G. Khakoo, Nidah Nazal, Leyla Frager, Shalom Demir, Nurhan Irak, Kader Melekoğlu Ellik, Zeynep Kacmaz, Hüseyin Balaban, Yasemin Atay, Kadri Eren, Fatih Alvares da-Silva, Mario R. Cristoferi, Laura Urzua, Álvaro Eşkazan, Tuğçe Magro, Bianca Snijders, Romee Barutçu, Sezgin Lytvyak, Ellina Zazueta, Godolfino M. Demirezer Bolat, Aylin Aydın, Mesut Amorós Martín, Alexandra Noemí De Martin, Eleonora Ekin, Nazım Yıldırım, Sümeyra Yavuz, Ahmet Bıyık, Murat Narro, Graciela C. Bıyık, Murat Kıyıcı, Murat Kahramanoğlu Aksoy, Evrim Vincent, Maria Carr, Rotonya M. Günşar, Fulya Reyes, Eira C. Harputluoğlu, Murat Aloman, Costica Gatselis, Nikolaos K. Üstündağ, Yücel Brahm, Javier Vargas, Nataly C. E. Güzelbulut, Fatih Garcia, Sandro R. Aguirre, Jonathan Anders, Margarita Ratusnu, Natalia Hatemi, Ibrahim Mendizabal, Manuel Floreani, Annarosa Fagiuoli, Stefano Silva, Marcelo Idilman, Ramazan Satapathy, Sanjaya K. Silveira, Marina Drenth, Joost P. H. Dalekos, George N. N.Assis, David Björnsson, Einar Boyer, James L. Yoshida, Eric M. Invernizzi, Pietro Levy, Cynthia Montano Loza, Aldo J. Schiano, Thomas D. Ridruejo, Ezequiel Wahlin, Staffan |
author |
Efe, Cumali |
author_facet |
Efe, Cumali Lammert, Craig Taşçılar, Koray Dhanasekaran, Renumathy Ebik, Berat Higuera de la Tijera, Fatima Calışkan, Ali R. Peralta, Mirta Gerussi, Alessio Massoumi, Hatef Catana, Andreea M. Purnak, Tugrul Rigamonti, Cristina Aldana, Andres J. G. Khakoo, Nidah Nazal, Leyla Frager, Shalom Demir, Nurhan Irak, Kader Melekoğlu Ellik, Zeynep Kacmaz, Hüseyin Balaban, Yasemin Atay, Kadri Eren, Fatih Alvares da-Silva, Mario R. Cristoferi, Laura Urzua, Álvaro Eşkazan, Tuğçe Magro, Bianca Snijders, Romee Barutçu, Sezgin Lytvyak, Ellina Zazueta, Godolfino M. Demirezer Bolat, Aylin Aydın, Mesut Amorós Martín, Alexandra Noemí De Martin, Eleonora Ekin, Nazım Yıldırım, Sümeyra Yavuz, Ahmet Bıyık, Murat Narro, Graciela C. Kıyıcı, Murat Kahramanoğlu Aksoy, Evrim Vincent, Maria Carr, Rotonya M. Günşar, Fulya Reyes, Eira C. Harputluoğlu, Murat Aloman, Costica Gatselis, Nikolaos K. Üstündağ, Yücel Brahm, Javier Vargas, Nataly C. E. Güzelbulut, Fatih Garcia, Sandro R. Aguirre, Jonathan Anders, Margarita Ratusnu, Natalia Hatemi, Ibrahim Mendizabal, Manuel Floreani, Annarosa Fagiuoli, Stefano Silva, Marcelo Idilman, Ramazan Satapathy, Sanjaya K. Silveira, Marina Drenth, Joost P. H. Dalekos, George N. N.Assis, David Björnsson, Einar Boyer, James L. Yoshida, Eric M. Invernizzi, Pietro Levy, Cynthia Montano Loza, Aldo J. Schiano, Thomas D. Ridruejo, Ezequiel Wahlin, Staffan |
author_role |
author |
author2 |
Lammert, Craig Taşçılar, Koray Dhanasekaran, Renumathy Ebik, Berat Higuera de la Tijera, Fatima Calışkan, Ali R. Peralta, Mirta Gerussi, Alessio Massoumi, Hatef Catana, Andreea M. Purnak, Tugrul Rigamonti, Cristina Aldana, Andres J. G. Khakoo, Nidah Nazal, Leyla Frager, Shalom Demir, Nurhan Irak, Kader Melekoğlu Ellik, Zeynep Kacmaz, Hüseyin Balaban, Yasemin Atay, Kadri Eren, Fatih Alvares da-Silva, Mario R. Cristoferi, Laura Urzua, Álvaro Eşkazan, Tuğçe Magro, Bianca Snijders, Romee Barutçu, Sezgin Lytvyak, Ellina Zazueta, Godolfino M. Demirezer Bolat, Aylin Aydın, Mesut Amorós Martín, Alexandra Noemí De Martin, Eleonora Ekin, Nazım Yıldırım, Sümeyra Yavuz, Ahmet Bıyık, Murat Narro, Graciela C. Kıyıcı, Murat Kahramanoğlu Aksoy, Evrim Vincent, Maria Carr, Rotonya M. Günşar, Fulya Reyes, Eira C. Harputluoğlu, Murat Aloman, Costica Gatselis, Nikolaos K. Üstündağ, Yücel Brahm, Javier Vargas, Nataly C. E. Güzelbulut, Fatih Garcia, Sandro R. Aguirre, Jonathan Anders, Margarita Ratusnu, Natalia Hatemi, Ibrahim Mendizabal, Manuel Floreani, Annarosa Fagiuoli, Stefano Silva, Marcelo Idilman, Ramazan Satapathy, Sanjaya K. Silveira, Marina Drenth, Joost P. H. Dalekos, George N. N.Assis, David Björnsson, Einar Boyer, James L. Yoshida, Eric M. Invernizzi, Pietro Levy, Cynthia Montano Loza, Aldo J. Schiano, Thomas D. Ridruejo, Ezequiel Wahlin, Staffan |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
AUTOIMMUNITY AZATHIOPRINE BUDESONIDE LIVER TRANSPLANTATION MERCAPTOPURINE SARS-COV-2 COVID-19 |
topic |
AUTOIMMUNITY AZATHIOPRINE BUDESONIDE LIVER TRANSPLANTATION MERCAPTOPURINE SARS-COV-2 COVID-19 |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH. Fil: Efe, Cumali. Harran University Hospita; Turquía Fil: Lammert, Craig. University School of Medicine Indianapolis; Estados Unidos Fil: Taşçılar, Koray. Universitat Erlangen-Nuremberg; Alemania Fil: Dhanasekaran, Renumathy. University of Stanford; Estados Unidos Fil: Ebik, Berat. Gazi Yasargil Education And Research Hospital; Turquía Fil: Higuera de la Tijera, Fatima. Hospital General de México; México Fil: Calışkan, Ali R.. No especifíca; Fil: Peralta, Mirta. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; Argentina Fil: Gerussi, Alessio. Università degli Studi di Milano; Italia Fil: Massoumi, Hatef. No especifíca; Fil: Catana, Andreea M.. Harvard Medical School; Estados Unidos Fil: Purnak, Tugrul. University of Texas; Estados Unidos Fil: Rigamonti, Cristina. Università del Piemonte Orientale ; Italia Fil: Aldana, Andres J. G.. Fundacion Santa Fe de Bogota; Colombia Fil: Khakoo, Nidah. Miami University; Estados Unidos Fil: Nazal, Leyla. Clinica Las Condes; Chile Fil: Frager, Shalom. Montefiore Medical Center; Estados Unidos Fil: Demir, Nurhan. Haseki Training And Research Hospital; Turquía Fil: Irak, Kader. Kanuni Sultan Suleyman Training And Research Hospital; Turquía Fil: Melekoğlu Ellik, Zeynep. Ankara University Medical Faculty; Turquía Fil: Kacmaz, Hüseyin. Adıyaman University; Turquía Fil: Balaban, Yasemin. Hacettepe University; Turquía Fil: Atay, Kadri. No especifíca; Fil: Eren, Fatih. No especifíca; Fil: Alvares da-Silva, Mario R.. Universidade Federal do Rio Grande do Sul; Brasil Fil: Cristoferi, Laura. Università degli Studi di Milano; Italia Fil: Urzua, Álvaro. Universidad de Chile; Chile Fil: Eşkazan, Tuğçe. Cerrahpaşa School of Medicine; Turquía Fil: Magro, Bianca. No especifíca; Fil: Snijders, Romee. No especifíca; Fil: Barutçu, Sezgin. No especifíca; Fil: Lytvyak, Ellina. University of Alberta; Canadá Fil: Zazueta, Godolfino M.. Instituto Nacional de la Nutrición Salvador Zubiran; México Fil: Demirezer Bolat, Aylin. Ankara City Hospital; Turquía Fil: Aydın, Mesut. Van Yuzuncu Yil University; Turquía Fil: Amorós Martín, Alexandra Noemí. No especifíca; Fil: De Martin, Eleonora. No especifíca; Fil: Ekin, Nazım. No especifíca; Fil: Yıldırım, Sümeyra. No especifíca; Fil: Yavuz, Ahmet. No especifíca; Fil: Bıyık, Murat. Necmettin Erbakan University; Turquía Fil: Narro, Graciela C.. Instituto Nacional de la Nutrición Salvador Zubiran; México Fil: Bıyık, Murat. Uludag University; Turquía Fil: Kıyıcı, Murat. No especifíca; Fil: Kahramanoğlu Aksoy, Evrim. No especifíca; Fil: Vincent, Maria. No especifíca; Fil: Carr, Rotonya M.. University of Pennsylvania; Estados Unidos Fil: Günşar, Fulya. No especifíca; Fil: Reyes, Eira C.. Hepatology Unit. Hospital Militar Central de México; México Fil: Harputluoğlu, Murat. Inönü University School of Medicine; Turquía Fil: Aloman, Costica. Rush University Medical Center; Estados Unidos Fil: Gatselis, Nikolaos K.. University Hospital Of Larissa; Grecia Fil: Üstündağ, Yücel. No especifíca; Fil: Brahm, Javier. Clinica Las Condes; Chile Fil: Vargas, Nataly C. E.. Hospital Nacional Almanzor Aguinaga Asenjo; Perú Fil: Güzelbulut, Fatih. No especifíca; Fil: Garcia, Sandro R.. Hospital Iv Víctor Lazarte Echegaray; Perú Fil: Aguirre, Jonathan. Hospital Angeles del Pedregal; México Fil: Anders, Margarita. Hospital Alemán; Argentina Fil: Ratusnu, Natalia. Hospital Regional de Ushuaia; Argentina Fil: Hatemi, Ibrahim. No especifíca; Fil: Mendizabal, Manuel. Universidad Austral; Argentina Fil: Floreani, Annarosa. Università di Padova; Italia Fil: Fagiuoli, Stefano. No especifíca; Fil: Silva, Marcelo. Universidad Austral; Argentina Fil: Idilman, Ramazan. No especifíca; Fil: Satapathy, Sanjaya K.. No especifíca; Fil: Silveira, Marina. University of Yale. School of Medicine; Estados Unidos Fil: Drenth, Joost P. H.. No especifíca; Fil: Dalekos, George N.. No especifíca; Fil: N.Assis, David. University of Yale. School of Medicine; Estados Unidos Fil: Björnsson, Einar. No especifíca; Fil: Boyer, James L.. University of Yale. School of Medicine; Estados Unidos Fil: Yoshida, Eric M.. University of British Columbia; Canadá Fil: Invernizzi, Pietro. Università degli Studi di Milano; Italia Fil: Levy, Cynthia. University of Miami; Estados Unidos Fil: Montano Loza, Aldo J.. University of Alberta; Canadá Fil: Schiano, Thomas D.. No especifíca; Fil: Ridruejo, Ezequiel. Universidad Austral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina Fil: Wahlin, Staffan. No especifíca; |
description |
Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/172868 Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; et al.; Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis; Wiley Blackwell Publishing, Inc; Liver International; 42; 3; 11-2021; 607-614 1478-3223 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/172868 |
identifier_str_mv |
Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; et al.; Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis; Wiley Blackwell Publishing, Inc; Liver International; 42; 3; 11-2021; 607-614 1478-3223 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1111/liv.15121 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613129083813888 |
score |
13.070432 |